
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Audits of the Top Science fiction Movies This Year - 2
This country music star spent years hiding his sexuality. Coming out — and beating addiction — has made his soul feel '20 pounds lighter.' - 3
7 Extraordinary Efficiency Applications for Experts - 4
Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief - 5
5 Eating routine Well disposed Snacks to Keep You Fulfilled
Flu season is ramping up, and some experts are "pretty worried"
‘Raising 10 red flags’: Is Israel’s army exhausted?
With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
Which Countries Would Suffer Most in a Global Energy Shutdown? This Study Has Answers
Magnetic fossils may reveal ancient creature's internal 'GPS system'
My Enterprising Excursion: Building a Startup
JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.
Lilly, Novo lock horns in India's obesity drug race
Voting begins in Uganda’s presidential election during internet shutdown and polling station delays












